Scholarlink

Purpose <p>The aim of this study was to evaluate the outcome, especially disease-free survival (DFS) and recurrence patterns, in patients with a&#xa0;maximum age of&#xa0;45&#xa0;years at first diagnosis of head and neck squamous cell carcinoma (HNSCC).</p> Methods <p>We retrospectively reviewed data from 79&#xa0;patients with newly diagnosed HNSCC aged&#xa0;45 or younger without distant metastasis who underwent postoperative or definitive radio(chemo)therapy in either the Department of Radiation Oncology at the University Hospital of Erlangen or the Department of Radiation Oncology at the University Hospital of Mainz between September 2006 and December 2023. The Kaplan–Meier method was used to calculate survival and recurrence rates. In univariate analysis, the log-rank test was used to correlate patient-/tumour- and treatment-related parameters to survival and recurrence rates.</p> Results <p>The overall survival rate was 79.7% at 2&#xa0;years and 67.1% at 5&#xa0;years. The DFS rate was 73.4% at 2&#xa0;years and 67.1% at 5&#xa0;years. Cumulatively, 14.6% of patients in the postoperative arm had locoregional recurrences at 2&#xa0;years and 23.0% at 5&#xa0;years, while 25.7% of patients in the definitive arm had local recurrences at 2&#xa0;years and 33.1% at 5&#xa0;years (<i>p</i> = 0.36). The rate of distant metastasis was 19.2% in the postoperative arm at 2&#xa0;years and 21.6% at 5&#xa0;years. In the definitive arm, the distant metastasis rate was 20.7% at 2&#xa0;years and 28.6% at 5&#xa0;years (<i>p</i> = 0.49). Disease-free survival was significantly improved in patients who drank little or no alcohol (<i>p</i> = 0.005) and in patients with a&#xa0;low UICC stage (<i>p</i> &lt; 0.001). No differences in DFS were observed for different primary tumour locations or treatment modalities.</p> Conclusion <p>Locoregional recurrences were the most common site of recurrence, regardless of tumour location and treatment modality. Therefore, future study designs in this patient cohort should potentially investigate intensified treatment approaches.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Head and neck squamous cell carcinoma in adults aged 45 or younger—an analysis of two tertiary cancer centres

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月21日

查看全文
  • Charlotte Frei,
  • Soeren Schnellhardt,
  • Sabine Semrau,
  • Sarina K. Mueller,
  • Manuel Weber,
  • Justus Kaufmann,
  • Rainer Fietkau,
  • Sophia Drabke,
  • Marlen Haderlein

摘要

Purpose

The aim of this study was to evaluate the outcome, especially disease-free survival (DFS) and recurrence patterns, in patients with a maximum age of 45 years at first diagnosis of head and neck squamous cell carcinoma (HNSCC).

Methods

We retrospectively reviewed data from 79 patients with newly diagnosed HNSCC aged 45 or younger without distant metastasis who underwent postoperative or definitive radio(chemo)therapy in either the Department of Radiation Oncology at the University Hospital of Erlangen or the Department of Radiation Oncology at the University Hospital of Mainz between September 2006 and December 2023. The Kaplan–Meier method was used to calculate survival and recurrence rates. In univariate analysis, the log-rank test was used to correlate patient-/tumour- and treatment-related parameters to survival and recurrence rates.

Results

The overall survival rate was 79.7% at 2 years and 67.1% at 5 years. The DFS rate was 73.4% at 2 years and 67.1% at 5 years. Cumulatively, 14.6% of patients in the postoperative arm had locoregional recurrences at 2 years and 23.0% at 5 years, while 25.7% of patients in the definitive arm had local recurrences at 2 years and 33.1% at 5 years (p = 0.36). The rate of distant metastasis was 19.2% in the postoperative arm at 2 years and 21.6% at 5 years. In the definitive arm, the distant metastasis rate was 20.7% at 2 years and 28.6% at 5 years (p = 0.49). Disease-free survival was significantly improved in patients who drank little or no alcohol (p = 0.005) and in patients with a low UICC stage (p < 0.001). No differences in DFS were observed for different primary tumour locations or treatment modalities.

Conclusion

Locoregional recurrences were the most common site of recurrence, regardless of tumour location and treatment modality. Therefore, future study designs in this patient cohort should potentially investigate intensified treatment approaches.